Delivery Order SPE2DB22D1017-SPE2DB24FG4EZ

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,283.49 firm fixed-price delivery order is for the supply of 4,565,622,917 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of August 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vyvanse 40 mg capsules in quantities of 100s. The $3,666.60 firm fixed price delivery order has a completion date of June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for supplying a comprehensive range of...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,879.60 firm fixed-price delivery order is for the supply of Vyvanse 40 mg capsules and has an ultimate completion date of April 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,680.05 firm fixed-price delivery order contract is for the supply of Vyvanse 20 mg capsules. The contract has a completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,016.48 firm fixed-price delivery order is for the supply of 100 units of the prescription medication Vyvanse (40 mg capsules). The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,388.96 firm fixed-price delivery order is for the supply of Vyvanse 60 mg capsules in 100-count bottles. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, valued at $4,216.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 40 mg capsules. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 6, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,757.24 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.95 firm-fixed-price delivery order is for the supply of 4,566,340,680 units of the prescription drug Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award of $22,961.32 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30mg capsules. The contract, which has a completion date of August 7, 2024, is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen is the prime contractor for this award, and the contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG4EZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,630.50 firm fixed-price delivery order is for the supply of Vyvanse 40 mg capsules, a prescription medication. The contract has an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies, leveraging its extensive pharmaceutical and medical supply chain to serve as a critical vendor for the U.S. government. This specific contract award does not have a set-aside designation.

Generated 11/28/24, 9:31 AM